Area of research
Psychiatry and Mental health · Cellular and Molecular Neuroscience
Research interest
Research interests include Bipolar Disorder and Treatment, Schizophrenia research and treatment, Tryptophan and brain disorders, and Neurotransmitter Receptor Influence on Behavior.
Recent Secular Trends of Body Mass Index in Individuals With Bipolar Disorders and in the General Population
Genome-wide association study of patients with a severe major depressive episode treated with electroconvulsive therapy
Cerebrospinal fluid proteomics targeted for central nervous system processes in bipolar disorder
Genomic and drug target evaluation of 90 cardiovascular proteins in 30,931 individuals
Characteristics of bipolar I and II disorder: A study of 8766 individuals
Prospective cohort study of early biosignatures of response to lithium in bipolar-I-disorders: overview of the H2020-funded R-LiNK initiative
International Consortium on the Genetics of Electroconvulsive Therapy and Severe Depressive Disorders (Gen-ECT-ic)
An enzyme in the kynurenine pathway that governs vulnerability to suicidal behavior by regulating excitotoxicity and neuroinflammation
Cerebrospinal fluid metabolomics identifies a key role of isocitrate dehydrogenase in bipolar disorder: evidence in support of mitochondrial dysfunction hypothesis
Blood metabolomics analysis identifies abnormalities in the citric acid cycle, urea cycle, and amino acid metabolism in bipolar disorder
Monocyte and microglial activation in patients with mood-stabilized bipolar disorder
Dietary intake, resting energy expenditure, and eating behavior in women with and without polycystic ovary syndrome
CSF neuroinflammatory biomarkers in bipolar disorder are associated with cognitive impairment
Apolipoprotein E Genotype and the Diagnostic Accuracy of Cerebrospinal Fluid Biomarkers for Alzheimer Disease
Abnormality in serum levels of mature brain-derived neurotrophic factor (BDNF) and its precursor proBDNF in mood-stabilized patients with bipolar disorder: A study of two independent cohorts
Increased cerebrospinal fluid interleukin-8 in bipolar disorder patients associated with lithium and antipsychotic treatment
Markers of glutamate signaling in cerebrospinal fluid and serum from patients with bipolar disorder and healthy controls
Neurocognitive function in bipolar disorder: a comparison between bipolar I and II disorder and matched controls